Clinical Trial Update: Effects of Citalopram on Hostility and CHD Risk [NA]

View source ↗

Summary

This clinical trial evaluated whether citalopram affects hostility and the risk of coronary artery disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CELEXA (citalopram)

Snippet

Sponsor: University of Pittsburgh | Conditions: Cardiovascular Diseases, Heart Diseases | NA | Status: COMPLETED